Researchers at Texas A&M University model extreme conditions using 3D bioprinting, revealing insights that could make flight ...
SCHLIEREN, ZüRICH, SWITZERLAND, November 11, 2025 /EINPresswire.com/ -- InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems ...
The effectiveness of non-clinical drug safety predictions is enhanced by the adoption of three-dimensional (3D) cellular models. 3D bioprinting enables the generation of complex models with spatial ...
In associate professor Mauro Tambasco's lab, researchers at all levels work together to develop innovative approaches to ...
Researchers recently developed a bone marrow model to study how the body generates cells. Interestingly, this model is the ...
Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...
Researchers developed a new 3D model of Alzheimer’s Disease that allows them to study the role of immune cells in the disease They found that infiltration of immune cells significantly increases in ...
Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...
U-shaped microcavities made of PEG hydrogel ensure consistent, uniform organoid formation for reliable 3D culture results. InSphero Logo InSphero acquires DOPPL SA and Sun Bio’s Gri3D® platform, ...
(MENAFN- EIN Presswire) EINPresswire/ -- InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed the definitive agreement to acquire the DOPPL SA, a ...